Stay updated on De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Sign up to get notified when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.

Latest updates to the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3 on the page. This reflects a backend/template maintenance update and does not alter study details shown to users.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedSite revision updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded the keyword 'Squamous cell carcinoma of the head and neck' to the page's keyword/MeSH terms.SummaryDifference0.0%

- Check56 days agoChange DetectedUpdated the site revision to v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.0%

- Check63 days agoChange DetectedFooter revision label updated to v3.4.3; the previous v3.4.2 label was removed.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded Oropharynx cancer as a topic and a Resources section linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

Stay in the know with updates to De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.